PMID: 6538301Apr 1, 1984Paper

Multiple sclerosis in Finland: evidence of increasing frequency and uneven geographic distribution

Neurology
E Kinnunen

Abstract

For the present incidence study of multiple sclerosis (MS) in Finland, reliable data since 1964 were available. The mean annual incidence rate of MS was significantly higher in the western part (3.3 per 100,000) than in the southern part of the country (2.2 per 100,000). The mean annual incidence for all MS patients was highest during the second of the three 5-year periods from 1964 to 1978. However, the incidence for women in the western part increased also thereafter. At the same time, the female-to-male incidence ratio changed from 1.0 to 2.2. The results confirmed an uneven distribution with a stable cluster of MS in the western part of the country.

Citations

Dec 31, 1986·The Science of the Total Environment·E HäsänenP Alhonen
Aug 1, 1989·The Science of the Total Environment·D G IrvineW J Hader
Apr 10, 2003·Annals of Epidemiology·Ya-Ping JinHans Link
Mar 1, 1991·Acta Neurologica Scandinavica·S PoserF A Stichnoth
Jan 1, 1995·Acta Neurologica Scandinavica. Supplementum·N Koch-Henriksen
Feb 1, 1987·Journal of Clinical Pathology·J A Morris
Jun 30, 2007·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Lawrence W SvensonDonald P Schopflocher
Sep 14, 2001·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·E G Celius, B Vandvik
Mar 1, 1991·Annals of Human Biology·T G MurrellI C Robinson
Jan 1, 1986·Journal of Chronic Diseases·K Lauer, W Firnhaber
Sep 1, 1989·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·L R HaaheimH Nyland
Jul 1, 1987·Neuropathology and Applied Neurobiology·A G DalgleishH E Webb
Sep 1, 1997·Clinical Immunology and Immunopathology·D L JacobsonN M Graham
Nov 14, 1985·Nature·H KoprowskiR C Gallo
Jun 25, 2008·Multiple Sclerosis : Clinical and Laboratory Research·S A WarrenK G Warren
Nov 28, 2018·Acta Neurologica Scandinavica·Anna-Leena PirttisaloJussi O T Sipilä
Jun 6, 2020·Acta Neurologica Scandinavica·Anna-Leena PirttisaloJussi O T Sipilä
Oct 2, 2002·Journal of Clinical Periodontology·Hiroshi OgawaHideo Miyazaki
Jul 10, 2002·Periodontology 2000·Aubrey Sheiham, Gopalakrishnan S Netuveli
Feb 1, 1993·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·A D Sadovnick, G C Ebers
Nov 30, 2018·Brain and Behavior·Daiva ValadkevicieneDalius Jatuzis
Dec 17, 2020·Journal of Neurology·Friederike NeußMatthias Grothe
Oct 1, 1993·Clinical Microbiology Reviews·J F Kurtzke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.